Glooko
Diabetes managment platform
Glooko has raised €31M across 1 funding round from 7 investors, most recently a Series C round in Jun 2017. Based in Sweden; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€31M
€30,732,037
Funding rounds
1
Investors
7
distinct backers
Active since
2017-06
latest 2017-06
Funding by year
EUR raised per yearGlooko — funding by year — interactive chart.
Data table
| Glooko — funding by year | |
|---|---|
| 2017 | €31M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-06-27 | Series C | €31M | Canaan Partners,Georgian,Insulet,Mayo Clinic,Medtronic,Samsung Next+1 more | View deal → |
Related news
Similar companies
same sector, similar size- Lifesum€18MSweden · Healthtech
- apotea.se€22MSweden · Healthtech
- ALung Technologies€34MUK · Healthtech
- InDex Pharmaceuticals€26MSweden · Healthtech
- Wilson Therapeutics€36MSweden · Healthtech
- SmartCella€32MSweden · Healthtech
Global coverage: FundingData